Search

everythinglearnresearchcommunity

for

Search:↓

Micrografts are a safe and effective treatment for hair loss in both men and women.

People with androgenetic alopecia are more likely to have metabolic syndrome.

About one-third of Saudi women with female pattern hair loss also have thinning hair at the back of their head.

PRP therapy with Derma roller effectively promotes hair re-growth and reduces hair fall in women with pattern hair loss.

Inositol and folic acid treatment significantly reduced hair loss and other symptoms in patients with androgenetic alopecia, but more research is needed for confirmation.

Prenatal and postnatal environments both affect PCOS development and gut microbiota in mice.

People with androgenetic alopecia often experience high stress, but the stress doesn't affect how the disease progresses or how well different treatments work.

Botulinum Toxin Type A can increase hair density and improve hair thickness in androgenetic alopecia with minimal side effects.

Severe hair loss may worsen with skin condition, suggesting treating the skin might help.

Low vitamin D levels may be linked to early hair loss in males.

Botulinum toxin A has limited effectiveness for 3 months in treating female pattern hair loss and may reduce scalp oiliness.

Low iron levels are linked to hair loss in women.

Hormonal imbalances contribute to female hair loss, and trichoscopy is a useful diagnostic tool.

Midscalp hair density and terminal hair percentage are good indicators of female pattern hair loss severity.

Telogen Effluvium causes increased hair shedding and can be challenging to diagnose and treat.

Patients with androgenetic alopecia have thinner subcutaneous fat layers in their frontal scalp compared to healthy individuals.

The treatment combining platelet-rich plasma and a non-cross-linked hyaluronic acid compound significantly improved hair density and reduced bald areas in women with androgenetic alopecia, and it's safe with only mild side effects.

Most COVID-19 patients in hospitals have androgenetic alopecia, more in men, suggesting a link between androgen sensitivity and severe COVID-19 symptoms.

Platelet-rich plasma, which carries growth factors, could be a promising treatment for non-scarring hair loss, promoting hair growth and density with no major side effects.

Female pattern hair loss is caused by multiple factors and while treatments like topical minoxidil, hormone therapy, and low-level light therapy can help, none can fully cure it.

Light therapy can stimulate hair growth and is more effective when started early, but more research is needed on its long-term effects and optimal use.

Adding low-level light therapy to minoxidil improves hair growth and patient satisfaction.

Women with PCOS often have depression and anxiety, so they should be checked for these issues.

The document concludes that using a person's own fat cells (SVF) can significantly increase hair thickness and density, suggesting it could be a promising treatment for hair loss.

High androgen levels cause skin issues in PCOS, affecting quality of life.

High levels of male hormones and irregular periods best predict how well PCOS patients will respond to metformin treatment.

Androgenetic alopecia is significantly linked to metabolic syndrome.

The treatment might help COVID-19 related hair loss, but more research is needed.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.